Asia Pacific Data Centre Market is anticipated to reach US$ 59.83 Billion by 2027

Asia-Pacific’s is one of the most agile developing data centre regions in the world. The growing importance of smart technologies, IoT-powered devices, Big Data, Industry 4.0, 5G and cloud computing has led to Data Centers (DC) taking on a more prominent role in businesses in recent times in the region. The factors driving the growth of the APAC data centre market are the implementation of 5G network triggering edge data centre investments, procurement of renewable energy, installation of innovative data centre technology, and artificial intelligence enhancing liquid immersion & direct-to-chip cooling adoption. According to Renub Research, the Asia Pacific Data Centre Market is expected to grow with a double-digit CAGR of 12.91% during 2020-2027.

Asia Pacific Data Centre Market by IT Infrastructure, Companies, Forecast

Data centers industry growth in India over the last few years has been considerable. Due to its fast growing economy, it has a strong potential to become a datacenter hub in the Asia Pacific region. The emergence of a new business environment, such as networking equipment, server and storage have significantly contributed towards collocation and data centre services among large enterprises and small & medium industries in India. The demand for data centers primarily identified from Banking, Financial Services and Insurance (BFSI), energy, government & defense, healthcare, manufacturing, IT &telecom and retail are massive.

Besides, country-specific in China, the demand for high-performance computing infrastructure is increasing due to IoT, artificial intelligence, and big data analytics. The adoption of blade type servers in data centres set to grow in the country. The majority of data centres in China have adopted blade servers for the high-density computing environment. The APAC Data centre Industry, as per our research findings, the APAC Datacenter Market is anticipated to reach US$ 59.83 Billion by 2027.

COVID-19 Impact on Datacenter Industry

Additionally, the APAC data centre market share has witnessed outstanding growth since the outbreak of the COVID-19 pandemic, which has expanded the access to internet-related assistance aided by lockdowns and restrictions imposed by government agencies across the region. Colocation service providers saw a strong uptake of data centre spaces by existing customers owing to the growth in demand during the pandemic.

In Japan, the data centre construction deposed no impact due to the pandemic; however, data center operators implemented stringent precautionary regulations for the safety of their employees. Hence, it expected that the market will witness a substantial spike in the announcement of new projects across APAC amidst the pandemic.

Key Players Analysis

The APAC data centre market has a strong presence of companies, including AT&T Inc., Equinix, Cisco, Microsoft and Google. The providers in the regions have conspired to fund millions of dollars in new facility expansion. Because of big data and technology boom tech companies are investing billions of dollars in data center infrastructure management. New trends are beginning to emerge given high data storage demand, fast speeds and power requirement. As per this research study, the Asia Pacific Data Centre Industry was US$ 25.58 Billion in 2020.

Renub Research new report “Asia Pacific Data Centre Market by IT Infrastructure (Networking Equipment, Server, Storage), End Users (Large Enterprises, Small & Medium Industries), Verticals (BFSI, Energy, Government & Defense, Healthcare, Manufacturing, IT &Telecom, Retail, Others), Country (China, India, Japan, Singapore, Australia), Company (AT&T Inc., Equinix, Cisco, Microsoft, Google)” provides a detailed analysis of Datacenter Industry in APAC.

Request a Free Sample Copy of the Report:https://www.renub.com/request-sample-page.php?gturl=asia-pacific-data-centre-market-p.php

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building and Construction, & Agriculture. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Our core team is comprised of experienced people holding graduate, postgraduate and PhD degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:
Renub Research
Phone No: +1 678–302–0700 (USA) | +91–120–421–9822 (IND)
Email: info@renub.com
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research

United States Diabetes Market will be USD 26.28 Billion by 2025

According to the latest report by Renub Research, titled “United States Diabetes Market, By Continuous Glucose Monitoring (CGM), Blood Glucose (SMBG) Device, Insulin Pen, Insulin Pump, Reimbursement Company Analysis & Forecast” Diabetes is the 7th leading cause of death in the United States as per Center for Disease Control and Prevention. Moreover, as per the report 88 million of adults have pre-diabetes. People with pre-diabetes have blood sugar levels which are high at the same time not quite enough that can be classified as type2 diabetes. Apart from type 1 and type2 diabetes there’s gestational diabetes which is common in some women at the time of pregnancy who don’t have diabetes. The United States Diabetes Market would be USD 26.28 Billion by 2025, according to Renub Research Analysis.

Diabetes Mellitus mostly called Diabetes is metabolic diseases which cause high blood sugar. With diabetes, body either doesn’t make enough insulin or can’t effectively use insulin which prior it make. Diabetes is one of the most costly chronic disease in the United States. Despite its prevalence, millions of people don’t know they have such disease. In the US, people with diabetes have health care cost more than that of the people who don’t have such disease.

In the United States, approximately 67.3% of the cost for diabetes care is provided by government insurance say Medicaid, Medicare, and the military and at the same time rest is paid for by private insurance 30.7% or by the uninsured 2% according to ADA. In the recent years, US government spends US$150 million in diabetes research at National Institute of Health most commonly called NIH.

The driving force towards this market growth are Rising Diabetes Mellitus in an Aging Population, Rising prevalence of diabetes in various age groups, Rising Government Funding for Diabetes Management, Benefits of Insulin Pump over Multiple Daily Injection, Lifestyle-Compatible Treatment Options and Technological Advancement in Insulin Pump.

However, there are few challenges also associated with diabetes industry such as Technological advancements in insulin infusion devices, Blood Glucose Meter Accuracy Problem, Low Compliance of Glucose Monitoring & Inadequate Reimbursement for SMBG Supplies, Safety Issues in Insulin Pump Devices, and Difficulties Associated with the Pump Adherence.

Request a Free Sample Copy of the Report:https://www.renub.com/request-sample-page.php?gturl=united-states-diabetes-market-p.php

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building and Construction, & Agriculture. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Our core team is comprised of experienced people holding graduate, postgraduate and PhD degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:
Renub Research
Phone No: +1 678–302–0700 (USA) | +91–120–421–9822 (IND)
Email: info@renub.com
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research

Sweden Diabetes Market, By CGM, SMBG, Insulin Pen & Pump, Companies

Sweden Diabetes market is increasing and continues to grow. In Sweden, diabetes prevalence has been projected to rise in future in adults 20–79 years, as a consequence of the ageing population. It is currently one of the most significant emergencies in terms of global health and shows an increasing prevalence in Sweden. The health care system of Sweden has taken a heavy toll due to diabetes, and this could be due to the associated direct costs required for medical management. But also because of indirect costs with regards to loss of productivity, early and premature mortality, and at the same time, the damage to a nations’ gross domestic product (GDP). According to Renub Research report, Sweden Diabetes Market is expected to be USD 5.82 Billion by the end of the year 2025.

In this report, Sweden Diabetic market is divided into four categories; GM, SMBG, Insulin Pump and Insulin Pen. All the four insulin delivery devices categories mentioned above are growing year on year. According to our analysis, the number of cases of diabetes will increase between 2011 and 2026. This increase is due to the change in population size and the rise in the number of old age population.

Companies Imitative in Sweden Diabetes Care Segment

• Sept 2018, Liva’s digital health program rolled out in the Sweden region. Liva Healthcare; introduces the innovative digital health coaching platform for scalable lifestyle and disease management.
• MAY 2020, Blighter’s Actiste service, for people living with insulin-treated diabetes, is available to consumers. Customers can easily sign up directly at the Artiste website.

Renub Research report titled “Sweden Diabetes Market & Forecast, By Self Monitoring Blood Glucose Device Analysis (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement) Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Insulin Pen Types (Disposable, Reusable & Smart Insulin Pen, Needle Market, Reimbursement Policies), Insulin Pump Market, (User and Reimbursement) Companies (Insulet Corporation, B. Braun Melsungen AG, LifeScan Inc., Artsana S.p.A, BD, Novo Nordisk A/S, Owen Mumford Ltd, Ypsomed AG, Medtronic, Eli Lilly and Company, Abbott Laboratories, Dexcom Inc and Roche)” provides a complete analysis of Germany Insulin Devices Market.

About Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)
Email: info@renub.com
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research

United Kingdom Diabetes Market, By CGM, SMBG, Insulin Pen & Pump, Companies

Diabetes mellitus is a condition in which the amount of glucose in the blood is too high because the body cannot use it properly. There are two types of diabetes; Type 1 and Type 2. The most common of the two types is Type 2 diabetes and its accounts for around 90 per cent of people with diabetes in the United Kingdom. The market of Insulin Pen, Insulin Pump, Continuous Glucose Monitoring (CGM) Device and Self Monitoring Blood Glucose Device are growing due to the rising awareness for diabetes in the United Kingdom. United Kingdom Diabetes Market is expected to reach USD 4.33 Billion by the year 2025.

In the United Kingdom, there are more than a million people diagnosed with diabetes, and the number continues to grow. Diabetes is one of the biggest health challenges the United Kingdom is facing today. Growing health crisis and its complications will increase awareness of the risks, improve self-management among people with diabetes bring about wholesale changes in lifestyle and improve access to integrated diabetes care services.

The National Service Framework (NSF) program is improving services by setting national standards to drive up service quality and tackle variations in care. In 2019, The Association of British HealthTech Industries (ABHI) had launched a diabetes section, enabling diabetes technology companies to work together in the first forum of its kind. ABHI group is for any health technology company with an interest in diabetes care from CGM and insulin pumps to apps.

Renub Research report titled “United Kingdom Diabetes Market & Forecast, By Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Self Monitoring Blood Glucose Device Analysis (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement) Insulin Pen Analysis – (User, Types – Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies), Insulin Pump Market, (Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, USA (By States) – Diabetes Supplies, Insulin Pump & Pump Supplies Reimbursement Policies by State-Sponsored Health Program) Companies (B. Braun Melsungen AG, Eli Lilly and Company, Artsana S.p.A, BD, Novo Nordisk A/S, Owen Mumford Ltd, Ypsomed AG, Medtronic, Insulet Corporation, LifeScan Inc., Abbott Laboratories)”

Request a free Brochure copy of the report: https://www.renub.com/request-sample-page.php?gturl=united-kingdom-diabetes-market-p.php

Segments Market based on Devices

  1. Continuous Glucose Monitoring (CGM)
  2. Self Monitoring Blood Glucose (SMBG)
  3. Insulin Pen
  4. Insulin Pump

United Kingdom Diabetes Sub-Segment Analysis

  1. Continuous Glucose Monitoring (CGM)
  2. Glucose Sensor Market & Forecast
  3. CGM Transmitter Market & Forecast
  4. CGM User
  5. CGM Reimbursement
  6. Self Monitoring Blood Glucose (SMBG)
  7. Test Strips Market and Forecast
  8. Lancet Market and Forecast
  9. Meter Market and Forecast
  10. Blood Glucose (SMBG) Users
  11. Blood Glucose Devices Reimbursement
  12. Insulin Pen
  13. Disposable Insulin Pen
  14. Reusable Insulin Pen
  15. Smart Insulin Pen
  16. Insulin Pen Needle Market
  17. Insulin Pen Users
  18. Reimbursement Policies
  19. Insulin Pump
  20. Insulin Pump Market
  21. Insulin Pump Users
  22. Reimbursement Policies

All the 14 Companies Studied in the Report have been Studied from 3 Points

• Company Overview
• Recent Developments
• Financial Insight

Company Analysis

  1. B. Braun Melsungen AG
  2. Eli Lilly and Company
  3. Artsana S.p.A
  4. BD
  5. Novo Nordisk A/S
  6. Owen Mumford Ltd
  7. Ypsomed AG
  8. Medtronic
  9. Insulet Corporation
  10. LifeScan Inc.
  11. Abbott Laboratories
  12. Roche
  13. Dexcom Inc

About Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)
Email: info@renub.com
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research

US Diabetes Market, By CGM, SMBG, Insulin Pen & Pump & Forecast to 2025 | Study with COVID-19 Impact

Renub Research report titled “United States Diabetes Market & Forecast, By Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Self Monitoring Blood Glucose Device Analysis (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement) Insulin Pen Analysis – (User, Types – Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies), Insulin Pump Market, (Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, USA (By States) – Diabetes Supplies, Insulin Pump & Pump Supplies Reimbursement Policies by State-Sponsored Health Program) Companies (B. Braun Melsungen AG, Eli Lilly and Company, Artsana S.p.A, BD, Novo Nordisk A/S, Owen Mumford Ltd, Ypsomed AG, Medtronic, Insulet Corporation, LifeScan Inc., Abbott Laboratories)” provides a complete analysis of United States Insulin Delivery Devices Market. Diabetes is rising at an alarming rate in the United States. Diabetes referred to as diabetes mellitus, is a group of metabolic diseases in which a person suffers from high blood glucose. If diabetes not appropriately monitored, then it can be fatal and cause serious health complications such as kidney diseases, heart diseases, amputation, stroke and blindness. Between the year 2000 and 2019, the number of people living with diabetes tripled and the number of new cases annually (incidence) doubled in the United States. The United States represents the third-largest diabetes patient pool owing to the increasing geriatric population and rising obesity levels in 2018. United States Diabetes Market is expected to reach USD 23.29 Billion by the year 2025.

The use of continuous glucose monitoring systems and continuous subcutaneous insulin infusion has gained full acceptance in diabetes care. These devices have demonstrated to be clinically valuable, reducing risks of hypoglycemia and improving glycemic control in ambulatory patients with type 1 diabetes & type 2 diabetes. Because of this tremendous improvement in the number of patients, especially that requiring insulin therapy, the cost of healthcare-related to diabetes and its complications is ever increasing. The market of Insulin Pen, Insulin Pump, Continuous Glucose Monitoring (CGM) Device and Self Monitoring Blood Glucose Device are growing due to the rise in numbers of diabetic patients in the United States.

The increasing diabetes prevalence has led the U.S. Government to launch diabetes to raise awareness and prevention programs about its symptoms and encourage healthier lifestyle behavior amongst the citizens. In 2019, Abbott Laboratories planned to ramp up manufacturing capacity for its lower-cost continuous glucose monitor (CGM) device in the next few years, targeting to reach millions of more patients worldwide, According to Reuters. In March 2018, Sanofi-aventis U.S. LLC received approval from the U.S. Food and Drug Administration for Toujeo Max SoloStar.

Request a free Sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=united-states-diabetes-market-p.php

About Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)
Email : info@renub.com
Web: https://www.renub.com
Fallow on Linkedin: https://www.linkedin.com/company/renub-research